CLINICAL_TRIALS
trial_result
· 2011-07-25
Clinical Trial Update: Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma [Phase 4]
Summary
A Phase 4 trial evaluating omalizumab in adults and adolescents with severe persistent allergic asthma has completed, with results posted in July 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2011-07-25